1. Home
  2. RVPH vs GORV Comparison

RVPH vs GORV Comparison

Compare RVPH & GORV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RVPH
  • GORV
  • Stock Information
  • Founded
  • RVPH 2006
  • GORV 1976
  • Country
  • RVPH United States
  • GORV United States
  • Employees
  • RVPH N/A
  • GORV N/A
  • Industry
  • RVPH Biotechnology: Pharmaceutical Preparations
  • GORV Retail-Auto Dealers and Gas Stations
  • Sector
  • RVPH Health Care
  • GORV Consumer Discretionary
  • Exchange
  • RVPH Nasdaq
  • GORV Nasdaq
  • Market Cap
  • RVPH 32.8M
  • GORV 25.3M
  • IPO Year
  • RVPH N/A
  • GORV 2015
  • Fundamental
  • Price
  • RVPH $0.40
  • GORV $6.64
  • Analyst Decision
  • RVPH Strong Buy
  • GORV Hold
  • Analyst Count
  • RVPH 5
  • GORV 2
  • Target Price
  • RVPH $9.00
  • GORV $2.00
  • AVG Volume (30 Days)
  • RVPH 3.8M
  • GORV 59.0K
  • Earning Date
  • RVPH 08-13-2025
  • GORV 08-15-2025
  • Dividend Yield
  • RVPH N/A
  • GORV N/A
  • EPS Growth
  • RVPH N/A
  • GORV N/A
  • EPS
  • RVPH N/A
  • GORV N/A
  • Revenue
  • RVPH N/A
  • GORV $767,257,000.00
  • Revenue This Year
  • RVPH N/A
  • GORV $15.65
  • Revenue Next Year
  • RVPH N/A
  • GORV $20.54
  • P/E Ratio
  • RVPH N/A
  • GORV N/A
  • Revenue Growth
  • RVPH N/A
  • GORV N/A
  • 52 Week Low
  • RVPH $0.30
  • GORV $3.95
  • 52 Week High
  • RVPH $4.28
  • GORV $106.20
  • Technical
  • Relative Strength Index (RSI)
  • RVPH 36.63
  • GORV 43.45
  • Support Level
  • RVPH $0.38
  • GORV $6.49
  • Resistance Level
  • RVPH $0.45
  • GORV $8.15
  • Average True Range (ATR)
  • RVPH 0.04
  • GORV 0.79
  • MACD
  • RVPH 0.01
  • GORV -0.05
  • Stochastic Oscillator
  • RVPH 58.54
  • GORV 17.04

About RVPH Reviva Pharmaceuticals Holdings Inc.

Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.

About GORV Lazydays Holdings Inc.

Lazydays Holdings Inc operates recreational vehicle dealerships. It provides products and services for RV owners and outdoor enthusiasts. The company generates revenue by providing a full spectrum of RV products: New and pre-owned RV sales, RV parts and services, financing and insurance products, third-party protection plans, after-market parts and accessories, and RV camping facilities.

Share on Social Networks: